COVID
Conditions
Brief summary
France and especially the region Grand Est have been damaged by the COVID-19 pandemic. This pandemic resulted in a reorganization of the hospitalization sectors. In order to better understand the disease, the investigators wish to carry out a descriptive analysis of hospitalized patient data. This study would notably allow us to identify some prognostic factors. The main objective of this study is to identify individual factors that are associated with a poor prognosis (with ICU admission or death).
Interventions
None listed
Sponsors
Centre Hospitalier Régional Metz-Thionville
Study design
Observational model
OTHER
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Patient hospitalized in COVID Unit at the Regional Hospital Center Metz-Thionville during the COVID 19 pandemic * PCR positive or COVID confirmed with clinical evidence and CT scan
Exclusion criteria
* Patients not willing to participate via using their medical files * Patient transferred after a brief stay in another hospital
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| ICU admission | Day 1 | Number of ICU admission during the hospitalization |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Length of stay at the ICU | Day 1 | The duration of stay at the ICU |
| Death | Day 1 | The occurrence of death during the stay |
| CT scan result | Day 1 | Evocative CT scan result |
| C reactive protein | Day 1 | C reactive protein value |
| Blood Count | Day 1 | Blood Count value |
| Sodium | Day 1 | Sodium value |
| Urea | Day 1 | Urea value |
| Troponine | Day 1 | Troponine value via biological data |
| Liver function | Day 1 | Transaminases value |
| Hospitalization | Day 1 | The duration of the hospitalization |
| Creatinine | day 1 | creatinine value |
| Clearance | day 1 | creatinine clearance value |
| Potassium | day 1 | potassium value |
| Calcium | day 1 | calcium value |
| Gamma-glutamyl transpeptidase | day 1 | Gamma-glutamyl transpeptidase value |
| Bilirubine | day 1 | Bilirubine value |
| Alcaline phosphatase | Day 1 | Alcaline phosphatase value |
| Prothrombine | Day 1 | Prothrombine value |
| Coagulation test | Day 1 | Quick test result |
Countries
France
Outcome results
None listed